Schubert & Co’s Bristol-Myers Squibb BMY Stock Holding History

Schubert & Co’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-267	Closed	-$18.5K	–	234
2023 Q1	$18.5K	Sell	267 -97	-27%	-$6.84K	0.02%	137
2022 Q4	$26.2K	Buy	364 +111	+44%	+$8.37K	0.02%	94
2022 Q3	$18K	Sell	253 -80	-24%	-$5.8K	0.02%	108
2022 Q2	$26K	Buy	333 +181	+119%	+$13.8K	0.02%	94
2022 Q1	$11K	Buy	152 +53	+54%	+$3.56K	0.01%	109
2021 Q4	$6K	Buy	+99	New	+$5.81K	0.01%	117

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Schubert & Co's BMY Position: Q2 2023 in Review

Schubert & Co sold out of Bristol-Myers Squibb (BMY) in Q2 2023, closing a stake of 267 shares — an estimated $18.5K sold.

Schubert & Co first reported a position in BMY in Q4 2021 and held it in 6 quarters. The position peaked at $26.2K in Q4 2022. 2,480 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

Schubert & Co reported no remaining Bristol-Myers Squibb position as of Q2 2023 after selling out during the quarter.
Schubert & Co sold 267 Bristol-Myers Squibb shares in Q2 2023, an estimated $18.5K.
Schubert & Co first reported a position in Bristol-Myers Squibb in Q4 2021 and held it in 6 quarters.
Schubert & Co's Bristol-Myers Squibb position peaked at $26.2K in Q4 2022.
2,480 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.